Research has shown that fidaxomicin, an antibiotic commonly used to treat intestinal infections, prevents the growth of resistant strains of Mycobacterium tuberculosis (MTb) that cause tuberculosis in the laboratory. 19 February 2021, 20:43 (NeBoley.com.ua)
You can vote until March 29. 26 March 2026, 22:49 (Зеркало недели)
Teenager's organs saved four patients. 11 April 2026, 13:18 (Обозреватель)